What Are Peptides? A Complete Guide to Peptide Science for Researchers

Quick answer: peptides are short chains of amino acids — the same building blocks that make up proteins, just shorter and more precise. The global peptide therapeutics market was valued at roughly $140.9 billion in 2025 and is projected to climb to $294.6 billion by 2033, growing at an 8.7% CAGR. That is not hype. That is a research field that has quietly become one of the fastest-moving corners of modern biochemistry, and it started with a single synthesized compound back in 1921.

If you have landed here trying to understand what peptides are before you order your first vial, read a COA, or design a study, this guide walks through the science first — no fluff, no miracle claims, just the mechanism, the evidence, and the numbers.

The Science, the Data, and What Researchers Actually Need to Know

What Are Peptides, Exactly?

Peptides are short strings of amino acids linked together by peptide bonds. Your body builds them constantly — insulin, oxytocin, and glucagon are all peptides your cells already produce and use to send signals between organs, tissues, and cells. Structurally, a peptide is usually described as a chain of somewhere between 2 and 100 amino acids. Cross that threshold, and biochemists start calling the molecule a protein instead.

That size matters more than it sounds like it should. Because peptides are small, they can be designed and synthesized with a level of precision that larger proteins don’t allow. You can target one specific receptor, one specific pathway, and leave the rest of the system alone — at least in theory, and that’s exactly what makes them such an active area of laboratory research right now.

Peptides vs. Proteins: Where the Line Actually Gets Drawn

Here’s a way to picture it: think of amino acids as letters, peptides as words, and proteins as full paragraphs. A dipeptide is two amino acids. A tripeptide is three. Once a chain folds into a complex three-dimensional structure and takes on a more elaborate biological role, researchers call it a protein.

The practical difference for a lab is this: peptides are generally easier to synthesize at high purity, easier to characterize by mass spectrometry, and easier to study in isolation. That’s a big part of why research peptides dominate so much of the current literature on cell signaling, metabolic pathways, and tissue research models.

How Peptides Work: Signaling, Not Just Structure

Most research peptides function as signaling molecules. They bind to a specific receptor on a cell’s surface, and that binding event triggers a cascade — a hormone gets released, a metabolic switch flips, a repair pathway activates. This is fundamentally different from how a structural protein like collagen works, where the molecule itself is the building material rather than the messenger.

Delivery method changes everything about how a peptide behaves in a research model. Absorption, half-life, and bioavailability all shift depending on whether a compound is studied via injection, topical application, or oral administration — which is exactly why the certificate of analysis and the storage conditions on a given batch matter so much for reproducible results.

A Brief History: From a 1921 Lab Bench to a $164 Billion Industry

Peptide science isn’t a TikTok trend, even though you’d be forgiven for thinking so given how often “peptides” shows up in your feed this year. Scientists first synthesized peptides in 1921, and insulin became the first lab-made peptide used medically, back in 1923. That’s over a century of continuous refinement.

Fast forward to now: there are more than 100 FDA-approved peptide drugs on the market today, treating everything from diabetes to osteoporosis to HIV. And the research pipeline behind them keeps expanding. According to Grand View Research, the global peptide therapeutics market sat at approximately $140.9 billion in 2025, is on track to hit roughly $164.0 billion in 2026, and is forecast to reach $294.6 billion by 2033. North America currently holds the largest share of that market — about 61.9% in 2025 — with the U.S. as the single biggest contributor, and Germany, the UK, and France anchoring the largest research markets in Europe.

What’s driving that growth? A few converging factors: rising rates of metabolic conditions like diabetes and obesity, the well-documented clinical success of GLP-1 receptor agonists, real advances in synthesis and purification technology, and expanding research applications in oncology, cardiovascular studies, and rare endocrine research.

The Major Categories of Research Peptides

Not all peptides are studied for the same reason. Broadly, the current research landscape breaks down into four major categories:

Metabolic Research Peptides

Compounds investigated in glucose-regulation and metabolic pathway models — this is the category that includes GLP-1 and GIP-related research compounds like semaglutide, tirzepatide, and AOD-9604, which sit at the center of the current metabolic research boom described above.

Recovery & Tissue Research Peptides

Peptides studied in tissue repair and cellular recovery models, most notably BPC-157 and TB-500, along with GHK-Cu. This is one of the categories where the gap between animal data and human evidence is widest — and where being precise about what the research actually shows (rather than what a forum post claims) matters most.

Growth Hormone Research Peptides

Growth hormone secretagogues and releasing peptides such as Sermorelin, Ipamorelin, and CJC-1295, studied for their effects on growth-hormone releasing pathways. We’ve covered the human-trial history of this category in detail in our Hexarelin research deep dive.

Cognitive Research Peptides

Nootropic-adjacent compounds like Semax, Selank, and Dihexa, investigated in neurological and cognitive research models. If this category interests you, our Semax research article breaks down four decades of data on one of the oldest compounds in the space.

What the Research Actually Shows — and Where It Stops

This is the part most peptide content skips, and it’s the part that matters most if you’re doing serious research. A huge amount of the excitement around research peptides is built on animal studies and in-vitro data, not human clinical trials. That doesn’t make the research meaningless — preclinical data is exactly how every approved drug starts — but it does mean the two categories of evidence need to be labeled and treated differently.

Take collagen peptides: oral collagen supplementation showed increased bone mineral density in at least one human study, and it’s broadly considered safe for most people. Compare that to many injectable wellness peptides, which remain outside FDA oversight, with limited long-term human safety data and purity that varies significantly between suppliers. The compound doesn’t tell you which category you’re in — the evidence does. That’s why, when we cover an individual compound in depth, like in our Retatrutide research article, we separate what the human data shows from what’s still only been demonstrated in animal models.

Purity, COAs, and Why Sourcing Is the Whole Game

Here’s the uncomfortable truth about research peptides: the compound name on the label tells you almost nothing. Purity, identity, and batch consistency are what actually determine whether your results are reproducible — and those three things are only verifiable through third-party testing.

A real Certificate of Analysis (COA) confirms a batch’s identity and purity using High Performance Liquid Chromatography (HPLC), the standard method for measuring peptide purity, and increasingly mass spectrometry for identity confirmation. Every batch we ship at Nexa Peptide Labs is independently tested to 99%+ HPLC-verified purity, with a COA available per lot and cold-chain shipping to protect compound stability from the moment it leaves the lab to the moment it reaches your bench. You can browse the full research peptide catalog and pull the COA for any lot before you ever add it to a cart. This is exactly the sourcing-to-COA pipeline Nexa Peptide Labs uses to protect research integrity — see how Nexa Peptide Labs reduces quality risk through sourcing, testing, and batch-level COAs.

Safety, Legal Status, and Research-Use Guidelines

All research peptides sold by Nexa Peptide Labs are intended strictly for laboratory and research use — not for human or animal consumption, and not evaluated by the FDA for any use outside a controlled research setting. That’s not a legal formality; it reflects where the actual evidence stands for most of these compounds. A small number of peptides, like insulin and a handful of GLP-1 drugs, have gone through the full approval process and are legitimately prescribed medications. The vast majority of compounds researchers are currently working with have not, and treating that distinction seriously is part of doing the research properly. Full details are in our research-use policy.

FAQs About What Are Peptides

What are peptides made of?

Peptides are made of amino acids — typically 2 to 100 of them — linked together by peptide bonds in a specific sequence that determines the molecule’s shape and function.

What is the difference between peptides and proteins?

Length and complexity. Peptides are shorter chains of amino acids (generally under 100), while proteins are longer chains that fold into more complex three-dimensional structures.

Why is everyone talking about peptides right now?

Largely because of the clinical success of GLP-1 receptor agonists like semaglutide and tirzepatide, which has renewed broad scientific and commercial interest in peptide-based research across metabolic, recovery, and cognitive categories.

Are peptides safe?

It depends entirely on the specific compound and its evidence base. FDA-approved peptide drugs like insulin have well-documented safety profiles. Many research-only peptides have limited human data, which is exactly why they’re sold strictly for laboratory research rather than human use.

What are peptides used for in research?

Current research applications span metabolic and glucose-regulation studies, tissue repair and recovery models, growth-hormone pathway research, and cognitive/neurological research, among others.

How do peptides work in the body?

Most peptides act as signaling molecules — they bind to specific receptors on cells and trigger a downstream biological response, such as hormone release or a metabolic pathway switch.

What’s the difference between peptides and GLP-1 drugs?

GLP-1 drugs like semaglutide are themselves peptides — specifically, peptides designed to mimic the GLP-1 hormone. The distinction that matters is regulatory: some GLP-1 peptides are FDA-approved prescription medications, while many other research peptides are not.

What is a Certificate of Analysis (COA), and why does it matter?

A COA is a third-party lab document confirming a specific batch’s identity and purity, typically measured via HPLC. It’s the only reliable way to verify what’s actually in a vial before using it in research.

Are research peptides legal to purchase?

Research peptides sold for laboratory use are legal to purchase in most jurisdictions when sold and used strictly for research purposes, not for human consumption. Regulations vary by country and compound, so it’s worth checking local requirements for your specific research application.

How should research peptides be stored?

Most require cold-chain handling and refrigeration or freezing to preserve stability, which is why proper shipping and storage documentation should always accompany a batch.

What’s the difference between research-grade and pharmaceutical-grade peptides?

Research-grade peptides are manufactured and tested for laboratory use and are not subject to the same regulatory approval process as pharmaceutical-grade compounds, which have gone through clinical trials and FDA review for a specific approved use.

The Bottom Line

Peptides are not a fad — they’re a century-old field of biochemistry that happens to be having a very public moment. Whether you’re studying metabolic pathways, tissue recovery, growth hormone signaling, or cognitive mechanisms, the fundamentals are the same: know the mechanism, separate animal data from human evidence, and never trust a compound without a batch-specific COA behind it. Explore Nexa Peptide Labs’ full catalog of HPLC-verified research peptides to see documentation for yourself before your next study.

References

• WebMD — What Are Peptides?
• Baylor Scott & White Health — What Are Peptides? A Beginner’s Guide
• Baptist Health — What Are Peptides and What’s All the Buzz About?
• Grand View Research — Peptide Therapeutics Market Size & Share Report

Research Use Only. Products discussed are intended solely for laboratory and research purposes, not for human or animal consumption, and have not been evaluated or approved by the FDA for any other use.